Biotech and Healthcare Portfolio 2021 as of 9/17
Biotech and Healthcare Portfolio as of 9/17 XLV up. 17% YTD led by UNH, IBB was improving up 14.6% YTD. U.S. MedTech leads with IHI up 24% YTD. MO small cap growth stocks represented by ARKG and XBI are lagging. We won't dig into an analysis at this moment while markets are in turmoil because...
Look for the Q4 Biotech Bounce in Mid-Small Caps…Update-1
Biotech Bounce in Mid-Small Caps- life science stocks find buyers. Bellwether tickers : ARKG up 3% to $83.93, XBI up 1.44% to $132.88. Update-1 ...Triple witching selling pressure again as expected but a little green at the end of day. DJI down 0.48%, NASDAQ down 0.91%, S&P 500 down 0.91%....
Small Cap Biotechs Sagging But More Deals Are Likely to Perk Up the Market…Update-1
Update-1 Five days of selling but looks like routine re-balancing at market highs. NASDAQ leads way down 0.7% Whether it is concerns about Washington or a seasonal buyers strike or even an extended summer vacation who knows? The 3.3% drop in AAPL on App Store ruling did not help. Here are some...
What’s Next for Biotech Stocks? …Update-1
Update-1 3:45P 9/1 FDA issues warning on JAK Inhibitor drug class. ABBV down 7%., PFE and LLY drugs also affected. Small cap rally intact: CRSP,CYRX, VCYT. Quidel (QDEL) up 5.45% on need for more COVID tests. ARKG and XBI up about 1.5%. Mid-caps all green. IBB up 0.96%. Barron's bullish on...
Healthcare Stocks Hit New Highs but Small Caps Lag…Update-2 Cyclicals Rally
Update-2 Powell talks taper as market rises. All indices were up in early trading with NASDAQ up 0.96%.Cyclicals were leading with energy XLE up 3%, industrials XLI up 0.88%, and XLF up 0.9%. A "risk-on" trade was developing with the IWM up 2.5% and the XBI up 3.12% to 132.59. All of our focus...
